Larimar Therapeutics, Inc.

NASDAQ:LRMR

Biotechnology

Healthcare
$2.99 +0.99%

+$0.04 today

Market cap
$310.61M
Beta
0.82
P/E (TTM)
-1.8
EPS (TTM)
-$1.95
52W Low $2.22High $6.42

Volume 1.38M

Average 1.73M

Price history

Larimar Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-11.80%

Period high

$5.95

Period low

$1.99

Latest

$2.99

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
4Nov 12, 2026Nov 12, 2026
4Nov 12, 2026Nov 12, 2026
4Nov 12, 2026Nov 12, 2026
4Nov 12, 2026Nov 12, 2026
4Nov 12, 2026Nov 12, 2026
4Nov 12, 2026Nov 12, 2026
4Nov 12, 2026Nov 12, 2026
8-KNov 9, 2026Nov 9, 2026
3Oct 1, 2026Oct 1, 2026
4Oct 1, 2026Oct 1, 2026
8-KSep 29, 2026Sep 29, 2026
10-QAug 4, 2026Aug 4, 2026
8-KAug 4, 2026Aug 4, 2026
4Jul 8, 2026Jul 8, 2026
8-KJun 29, 2026Jun 29, 2026

Competitors

Who does Larimar Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about LRMR's filings, answered from its disclosures.

What is the latest LRMR filing?

The latest filing shown is 4 dated Nov 12, 2026.

How many recent filings does LRMR have?

Intrinsic Alpha currently shows 20 recent filings for LRMR.